The inspirational quote ‘It takes all of us’ has reverberated through social justice and become a sporting mantra, hailing ...

Patient-reported outcomes (PROs) were similar among those treated with tivozanib monotherapy and those given combination ...

While most cancer research focuses on discovering new treatments, Dr Nicky Lawrence and Professor Nuala Helsby from Waipapa ...

T-knife Therapeutics, Inc., a biopharmaceutical company developing T cell receptor (TCR) engineered T cell therapies (TCR-T) ...

A multi-national, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a ...

Avelumab plus axitinib was effective and safe in real-world advanced kidney cancer, with outcomes matching clinical trials, according to AVION study findings.

Fascinating new research shows mollusk blood proteins have strong antimicrobial properties, especially when combined with ...

Collaboration reinforces Conduit’s commitment to leveraging AI and cybernetics to reduce human error, lower costs, and accelerate timelines in ...

A multi-national, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a ...

An exhibition showing how charity donations are supporting medical research has launched in Leeds. Our Research Story celebrates eight early career researchers who have been able to lead studies ...

A multi-national, multi-institutional study investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda.

The industry is on a strong growth trajectory, with experts predicting notable achievements over the next decade. Forecasts ...